Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""Enalapril maleate tablets, USP are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema. Do not coadminister aliskiren with enalapril maleate in patients with diabetes (see PRECAUTIONS, Drug Interactions Enalapril maleate tablets, USP are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer enalapril maleate tablets USP within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS , Head and Neck Angioedema"" assertion.
- association object DOID_1558 assertion.
- association predicate treats assertion.
- association subject drugbank:DB09477 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB09477 category Drug assertion.
- DOID_1558 category Disease assertion.
- association provided_by NeuroDKG assertion.